Innovative weight loss program for obese patients that need a kidney transplant
Infection, delayed kidney function, kidney loss and death are all risks associated with kidney transplant surgery in obese patients.
Jun 23, 2025
0
18
Amino Acids, Peptides, and Proteins: News and Research on Tirzepatide
MeSH tree: D12.776.631.650.300.001
The new generation of blockbuster weight-loss drugs, explained
A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few years, though they do have some drawbacks.
Jun 21, 2025
0
84
Wegovy and Mounjaro might affect how well your contraceptives work—here's why
Weight loss drugs, including Wegovy (semaglutide) and Mounjaro (tirzepatide), are becoming increasingly popular among those trying to lose weight. But a rise in so-called "Ozempic babies" has led the UK's medicines regulator ...
Jun 16, 2025
0
20
The weight loss drug Mounjaro has been approved to treat sleep apnea. How does it work?
Last week, Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition in which breathing stops and starts repeatedly during sleep.
Jun 12, 2025
0
24
Injectable medications for obesity found to produce smaller weight loss in a real-world setting
A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight loss in a real-world setting because patients discontinue treatment or use lower maintenance dosages. ...
Jun 10, 2025
0
38
UK warns about 'skinny jabs' if trying to get pregnant
The UK's medicine regulator warned Thursday against taking "skinny jabs" to fight weight loss if trying to get pregnant or while breastfeeding because of their unknown effects on babies.
Jun 5, 2025
0
9
Comorbid obesity and sleep apnea treatment preferences found to differ among patients and providers
A new study to be presented at the SLEEP 2025 annual meeting found that sleep medicine professionals favor continuous positive airway pressure therapy as treatment for comorbid obesity and obstructive sleep apnea, while patients ...
Jun 2, 2025
0
27
The role of GLP-1 receptor agonists in the management of obesity
As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights into the rapidly evolving use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as Ozempic ...
May 27, 2025
0
17
FDA halts sale of off-brand Ozempic and other GLP-1 drugs
A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.
May 23, 2025
0
222
Half of popular TikToks about 'food noise' mention medications to manage intrusive thoughts about food, study shows
A new analysis being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May), finds that around half of the 100 top TikTok videos about food noise reference the use of medications—mainly the popular ...
May 14, 2025
0
14
